Basilea

BASILEA NEWSROOM (6 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2025 2024 2023 2022 2018 2017 2014 2013 2012

Basilea’s Antifungal Drug Cresemba Surpasses Sales Threshold in Asia Pacific, Triggering $1.25 Million Milestone Payment

PRESS RELEASE -- 20, November 2023

(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company dedicated to addressing severe bacterial and fungal infections, has announced that its antifungal medication, Cresemba® (isavuconazole), has achieved robust sales performance in the Asia Pacific region and China through its licensing partner, … Read the full press release

Basilea Pharmaceutica Reports Strong H1 2023 Financial Results and Increases Full-Year Guidance

PRESS RELEASE -- 16, August 2023

(IN BRIEF) Basilea Pharmaceutica Ltd, a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced robust financial results for the first half-year ending June 30, 2023. Their CEO, David Veitch, highlighted the company’s progress in executing their … Read the full press release

Biotalys y Syngenta se asocian para desarrollar soluciones de biocontrol para el manejo de plagas

PRESS RELEASE -- 24, April 2023

(NOTICIA EN BREVE) Biotalys y Syngenta Crop Protection se están asociando para investigar, desarrollar y comercializar soluciones de biocontrol para manejar plagas en una amplia gama de cultivos. La solución se basará en la plataforma tecnológica AGROBODY de Biotalys, que … Read the full press release

Xofluza de Roche: el fármaco innovador contra la gripe aprobado para niños en Europa

PRESS RELEASE -- 12, January 2023

(COMUNICADO DE PRENSA) BASEL, 12-Jan-2023 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY), un pionero mundial en productos farmacéuticos y diagnóstico centrado en el avance de la ciencia para mejorar la vida de las personas, ha anunciado que la … Read the full press release